Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors sought to identify factors that moderate outcome in late-life major depression and that identify patients for whom antidepressants have clinically meaningful effects. METHOD: A previous systematic review identified 10 placebo-controlled trials of second-generation antidepressants in outpatients with major depressive disorder who were age 60 or older. For the present study, the authors obtained from the sponsors of the 10 trials individual patient data, including age, sex, duration of illness (current age minus age at onset), course (single episode or recurrent depression), baseline depression severity, treatment assignment, and outcomes. Logistic regression models were estimated and tested to examine the association of potential moderator variables with treatment response and the treatment group-response interaction. RESULTS: All moderator variables were collected and documented for seven of the 10 trials (N=2,283). Univariate and multivariate analyses were restricted to these seven trials. Illness duration was the only variable significantly associated with drug-placebo differences in the multivariate model. In patients with an illness duration >10 years, baseline depression severity was also significantly associated with drug-placebo differences. In those with an illness duration >10 years and a Hamilton Depression Rating Scale score ≥21, the drug-placebo difference in response rates was relatively robust (number needed to treat=4). In the remaining patients, the drug-placebo difference in response rates was small (46.3% compared with 41.5%). CONCLUSIONS: Older patients with a long illness duration and moderate to severe depression appear to benefit from antidepressants as compared with placebo. Antidepressants do not appear to be effective for older patients with short illness duration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Late-life depression (LLD) is a common and debilitating condition, with less frequent remission and more frequent recurrence following first-line antidepressant treatment compared to depression experienced earlier in life1–7.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [4]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 6×
“Hence, we did not assess the influence of MMSE score on outcome.”
MethodInfluentialStatistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 12×
“In the 385 patients with a long duration of illness (.10 years) and moderate to severe depression (HAM-D score $21), response rates were 58.0% and 31.4% in the drug and placebo groups, respectively (the effect size for the drug-placebo difference was 0.54), but in the remaining patients, the effect size was small (eff…”
MethodInfluentialAssessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · cited 1×
“All trials were sponsored by the manufacturer of the antidepressant and had Jadad scores of 4 or 5, indicating that the trials were of good to excellent methodological quality (58).”
MethodA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 6×
“To convert MADRS scores to 17-item HAM-D scores in one trial, we used a factor derived from a late-life major depression study that used both scales (47).”
MethodInfluentialTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442 · cited 2×
“As noted above, however, our findings are similar to those of previous meta-analyses and large trials with mixed-aged samples (27, 28, 31, 32).”
BackgroundResultAntidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
Research works printed but not linked: 1
- Salzman C, 1999, J Clin Psychiatry, 60, 30
Cited by
Management of Depression in Older Adults: A Review
Kok, R. M., & Reynolds, C. F. (2017) · JAMA · doi:10.1001/jama.2017.5706 · Cited by 890
MacQueen, G. M., Frey, B. N., Ismail, Z., Jaworska, N., Steiner, M., Lieshout, R. J. V., Kennedy, S. H., Lam, R. W., Milev, R. V., Parikh, S. V., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659276 · Cited by 248
“treatment response in LLD suggests older adults with longer illness duration and moderate to severe depression benefit from antidepressants compared to placebo, whereas short illness duration does not show antidepressant response.(130) Furthermore, executive dysfunction, especially in the subdomains of planning and or…”
BackgroundPsychobiological factors of resilience and depression in late life
Laird, K. T., Krause, B., Funes, C., & Lavretsky, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0424-7 · Cited by 229
Lavretsky, H., Reinlieb, M., St. Cyr, N., Siddarth, P., Ercoli, L. M., & Senturk, D. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070889 · Cited by 184
A Systematic Review and Meta-analysis of Psychotherapy for Late-Life Depression
Huang, A. X., Delucchi, K., Dunn, L. B., & Nelson, J. C. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.04.003 · Cited by 156
Self-citationPredictors of treatment outcome in depression in later life: A systematic review and meta-analysis
Tunvirachaisakul, C., Gould, R. L., Coulson, M., Ward, E. V., Reynolds, G., Gathercole, R. L., Grocott, H., Supasitthumrong, T., Tunvirachaisakul, A., Kimona, K., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.008 · Cited by 129
“In a patient-level meta-analysis, Nelson et al. (2013) reported three predictors that moderated drug- placebo differences from 10 RCTs of second-generation antidepressants in late-life depression; increased age, illness duration from first onset and depression severity.”
BackgroundTham, A., Jonsson, U., Andersson, G., Söderlund, A., Allard, P., & Bertilsson, G. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.013 · Cited by 104
Lorenzo‐Luaces, L., DeRubeis, R. J., van Straten, A., & Tiemens, B. G. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.010 · Cited by 110
Karim, H. T., Andreescu, C., Tudorascu, D., Smagula, S. F., Butters, M. A., Karp, J. F., Reynolds, C., & Aizenstein, H. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.55 · Cited by 95
Gebara, M. A., Lipsey, K. L., Karp, J. F., Nash, M. C., Iaboni, A., & Lenze, E. J. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.11.004 · Cited by 84
Kaneriya, S. H., Robbins-Welty, G. A., Smagula, S. F., Karp, J. F., Butters, M. A., Lenze, E. J., Mulsant, B. H., Blumberger, D., Anderson, S. J., Dew, M. A., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3447 · Cited by 59
Brimelow, R. E., Wollin, J. A., Byrne, G. J., & Dissanayaka, N. N. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218001229 · Cited by 66
“, 2014;Khouzam, 2009); however, treatment has been shown to be effective only for residents with severe, long lasting depression (Fournier et al., 2010; Nelson et al., 2013).”
BackgroundLavretsky, H., Laird, K. T., Krause-Sorio, B., Heimberg, B. F., Yeargin, J., Grzenda, A., Wu, P., Thana-Udom, K., Ercoli, L. M., & Siddarth, P. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.08.011 · Cited by 61
Yohannes, A. M., & Alexopoulos, G. S. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0186-0 · Cited by 58
“Evidence suggests that antidepressant drug therapies are effective in the treatment of moderate to severe depression in older patients with chronic physical illness, as compared with placebo [23].”
BackgroundDepression, Antidepressants, and Bone Health in Older Adults: A Systematic Review
Gebara, M. A., Shea, M. L. O., Lipsey, K. L., Teitelbaum, S. L., Civitelli, R., Müller, D. J., Reynolds, C. F., Mulsant, B. H., & Lenze, E. J. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12945 · Cited by 65
“In older adults, antidepressants are effective in the treatment of depression that is of longer duration and at least moderately severe.(46) In addition, when short-term treatment with an SRI antidepressant leads to remission of late-life depression, long-term maintenance treatment prevents recurrence.”
BackgroundMagnetic Resonance Imaging Predictors of Treatment Response in Late-Life Depression
Aizenstein, H. J., Khalaf, A., Walker, S. E., & Andreescu, C. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516541 · Cited by 53
“Several studies have examined the demographic, clinical, cognitive, imaging, and physiologic predictors of treatment response.(1-6,9-16) The current review provides an update focused on the use of magnetic resonance imaging (MRI) predictors of treatment response in geriatric depression.”
BackgroundWhite Matter Hyperintensity Accumulation During Treatment of Late-Life Depression
Khalaf, A. M., Edelman, K. L., Tudorascu, D. L., Andreescu, C., Reynolds, C. F., & Aizenstein, H. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.158 · Cited by 57
Baba, H., Kito, S., Nukariya, K., Takeshima, M., Fujise, N., Iga, J., Oshibuchi, H., Kawano, M., Kimura, M., Mizukami, K., et al. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13349 · Cited by 50
“One study showed that lifetime duration of depression was associated with lower placebo response rate, resulting in a larger drug–placebo difference.(29) In elderly patients, psychotic depression can be treated with combination therapy (antidepressants and antipsychotics) or electroconvulsive therapy (ECT) as effectiv…”
BackgroundCurcumin as a putative antidepressant
Seo, H., Wang, S., Han, C., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1008457 · Cited by 43
“According to a recent metaanalysis [99] of seven RCTs conducted in elderly depression patients, antidepressants may not be sufficiently effective in older patients with late-onset depression of short duration.”
BackgroundHsu, C., Tseng, W., Wang, L., Yang, Y., Kao, H.-Y., & Lin, P. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.009 · Cited by 40
Brimelow, R. E., Thangavelu, K., Beattie, R., & Dissanayaka, N. N. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.07.026 · Cited by 38
Management of Late-Life Depression
Nelson, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_170 · Cited by 43
Self-citationAdvances in Pharmacotherapy of Late-Life Depression
Beyer, J. L., & Johnson, K. G. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0899-6 · Cited by 41
Zazula, R., Husain, M. I., Mohebbi, M., Walker, A. J., Chaudhry, I. B., Khoso, A. B., Ashton, M. M., Agustini, B., Husain, N., Deakin, J., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420965697 · Cited by 31
“Either early or late onset of MDD increases treatment resistance as well as longer duration of the illness, constituting possible predictors of response to antidepressant treatments (De Carlo et al., 2016; Nelson et al., 2013; Perlman et al., 2019).”
BackgroundLorenzo‐Luaces, L., Rodríguez‐Quintana, N., & Bailey, A. J. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103637 · Cited by 31
“As other studies (Driessen et al., 2016; Hollon et al., 2014; Nelson et al., 2013), we found a significant interaction between depression severity and duration in predicting outcomes, this time with combination therapy or CBT vs.”
ResultDepression in Later-life: An Overview of Assessment and Management.
Dines, P. L., Hu, W., & Sajatovic, M. (2014) · PubMed · Cited by 36
Samara, M. T., Goldberg, Y., Levine, S. Z., Furukawa, T. A., Geddes, J. R., Cipriani, A., Davis, J. M., & Leucht, S. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30331-0 · Cited by 28
Clinic Visits in Late-Life Depression Trials: Effects on Signal Detection and Therapeutic Outcome
Rutherford, B. R., Tandler, J. M., Brown, P. J., Sneed, J. R., & Roose, S. P. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.09.003 · Cited by 28
Hoeft, T. J., Hinton, L., Liu, J., & Unützer, J. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.07.003 · Cited by 25
“depression highlight treatment resistant depressions as a high priority for the field (34, 37-51).”
Resilience predicts remission in antidepressant treatment of geriatric depression
Laird, K. T., Lavretsky, H., St. Cyr, N., & Siddarth, P. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4953 · Cited by 23
“However, a patient‐level meta‐analysis of 7 placebo‐controlled trials of second‐generation antidepressants for geriatric depression found that sex did not moderate treatment response.(5) Research investigating age of depression onset as a predictor of treatment response has also reported contradictory results.”
BackgroundLocher, C., Kossowsky, J., Gaab, J., Kirsch, I., Bain, P. A., & Krummenacher, P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.062 · Cited by 24
“Late-life depressive disorders also increase disability (Nelson et al., 2013), are associated with poorer outcomes in clinically significant illnesses (Jiang et al.”
BackgroundResultInfluentialSeripa, D., Pilotto, A., Paroni, G., Fontana, A., D’Onofrio, G., Gravina, C., Urbano, M., Cascavilla, L., Paris, F., Panza, F., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115578159 · Cited by 24
“It has variably been related to vascular disease, neurodegeneration, inflammatory processes and other age-related changes (Nelson et al., 2013; Panza et al., 2010; Richard et al., 2013).”
BackgroundResultInfluentialHolper, L. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.11.012 · Cited by 22
Effectiveness and predictors of outcome in routine out-patient mental health care for older adults
Veerbeek, M., Voshaar, R. C. O., & Pot, A. M. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000647 · Cited by 21
“A recent meta-analysis showed that in older adults with chronic depression (>10 years) more severe depression at baseline contributed to a better response to antidepressant treatment (Nelson et al., 2013).”
BackgroundTherapeutic relationship in the treatment of geriatric depression with executive dysfunction
Mace, R. A., Gansler, D. A., Suvak, M. K., Gabris, C., Areán, P. A., Raue, P. J., & Alexopoulos, G. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.006 · Cited by 20
Gitlin, L. N., Roth, D. L., & Huang, J. (2014) · Psychology and Aging · doi:10.1037/a0036784 · Cited by 17
Depressive symptomology management and falls among middle aged and older adults
Prizer, L. P., Smith, M. L., Housman, J. M., & Ory, M. G. (2015) · Aging & Mental Health · doi:10.1080/13607863.2015.1021748 · Cited by 19
Therapy Strategies for Late-life Depression: A Review
Piel, C., & Quante, A. (2023) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000678 · Cited by 17
Serotonin receptor inhibitor is associated with falls independent of frailty in older adults
Lin, S. M., Borges, M. K., de Siqueira, A. S. S., Biella, M. M., Filho, W. J., Cesari, M., Voshaar, R. C. O., & Aprahamian, I. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1675143 · Cited by 16
Dunn, B. D., O’Mahen, H., Wright, K. A., & Brown, G. P. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.103417 · Cited by 15
Lorenzo‐Luaces, L., Rodríguez‐Quintana, N., Riley, T. N., & Weisz, J. R. (2020) · Psychotherapy Research · doi:10.1080/10503307.2020.1747657 · Cited by 16
Thomson, L., Barker, M., Kaylor‐Hughes, C., Garland, A., Ramana, R., Morriss, R. K., Hammond, E. R., Hopkins, G., & Simpson, S. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1708-9 · Cited by 14
Ahmed, R., Boyd, B. D., Elson, D. M., Albert, K. M., Begnoche, J. P., Kang, H., Landman, B. A., Szymkowicz, S. M., Andrews, P., Vega, J. N., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722003579 · Cited by 20
“…2002; Tedeschini et al., 2011) and persistent depression is associated with poorer outcomes of medical illness, impaired cognition and dementia, and high rates of suicide (Katon, Unützer, & Russo, 2010; Mulsant, Blumberger, Ismail, Rabheru, & Rapoport, 2014; Nelson, Delucchi, & Schneider, 2013).”
Yonezawa, K., Uchida, H., Yatomi, T., Ohtani, Y., Nomoto‐Takahashi, K., Nakajima, S., Mimura, M., & Tani, H. (2023) · Pharmacopsychiatry · doi:10.1055/a-2179-8884 · Cited by 16
Plöderl, M., & Hengartner, M. P. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2230-4 · Cited by 12
Research status and global trends of late-life depression from 2004 to 2023: bibliometric analysis
Du, R., Yang, K., Li, W., Wang, Z., & Cai, H. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1393110 · Cited by 11
“Currently, evidence-based data in the elderly population show a significantly greater effect of antidepressants than placebo in patients with LLD (Nelson et al., 2013), but this advantage may not apply to patients ≥ 65 years (Mallery et al., 2019) but rather to the subgroup of patients aged 55– 65…”
BackgroundMosca, D., Zhang, M., Prieto, R., & Boucher, M. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000674 · Cited by 11
“Results of some analyses have indicated that change from baseline or effect size for efficacy outcomes may be smaller for older patients,(56,57) but that difference may be at least in part explained by a longer duration of illness in older patients.(60) Other studies have shown reduced efficacy for some antidepressant…”
BackgroundDepressionen im höheren Lebensalter, Teil 2: Komorbidität und Behandlung
Wolter, D. K. (2016) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-016-1022-4 · Cited by 9
“Diejenigen Patienten, die bereits früher in ihrem Leben unter Depressionen litten, respondieren besser [73, 78].”
Deprescribing Antidepressants in Older People ‐ Breaking Up Can Be Hard to Do
Mangin, D. A., & Siu, H. Y. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.228 · Cited by 7
End-of-Life Care in Advanced Dementia
Heron, C. R., & Simmons, B. B. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.10.2826 · Cited by 7
Li, H., Zhou, L., Liu, G., Wang, L., Zhao, Q., Shaohong, X., & Cai, E. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin27142 · Cited by 6
Lin, C.-Y., Wu, Y., Wang, H.-S., Chen, P.-K., Lin, Y.-F., & Chien, I. (2016) · Depression and Anxiety · doi:10.1002/da.22489 · Cited by 6
“4) with late-onset depression.[49] A recent metaanalysis suggested that psychotherapy benefits late-life depression, but the standardized mean difference scores of the treatment and control groups were lowered after limiting trials that only included MDD.”
BackgroundWatanabe, Y., Asami, Y., Hirano, Y., Kuribayashi, K., Itamura, R., & Imaeda, T. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s146428 · Cited by 6
Nakabayashi, T., Hara, A., & Minami, H. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.12.019 · Cited by 5
Ossola, P., Gerra, M. L., Luviè, L., Piacente, A., Marchesi, C., Schoretsanitis, G., & Stewart, J. W. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.02.013 · Cited by 3
Schoemaker, J. H., Kilian, S., Emsley, R. A., & Vingerhoets, A. J. J. M. (2018) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2018.04.002 · Cited by 3
Kiosses, D., Ravdin, L., Banerjee, S., Wu, Y.-Y., Henderson, C. R., Pantelides, J., Petti, E., Maisano, J., Meador, L., Kim, P., et al. (2025) · The American journal of geriatric psychiatry · doi:10.1016/j.jagp.2024.12.008 · Cited by 2
Fußer, F., Karakaya, T., & Pantel, J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198746638.003.0017 · Cited by 4
Regen, F., & Benkert, O. (2016) · Springer eBooks · doi:10.1007/978-3-662-50333-1_1 · Cited by 2
Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review
Mohler, J. M., Fain, M. J., Chen, Z., Lee, J. K., & Thienhaus, O. J. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13301 · Cited by 2
Moderators of treatment response in late-life depression
Steffens, D. C., Diniz, B. S., Jain, N., Kluewer-DAmico, J., Manning, K. J., & Wang, L. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02337-x · Cited by 1
Benkert, O. (2014) · Springer eBooks · doi:10.1007/978-3-642-54769-0_1 · Cited by 1
Greenstein, S. P., McGonigle, D. P., & Kellner, C. H. (2016) · Wiley eBooks · doi:10.1002/9781118654231.ch34 · Cited by 4
Nelson, J. C. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.02.015 · Cited by 1
Self-citationAccessibility and effectiveness of mental health care for older adults
Veerbeek, M. (2015) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Moderators of Remission in Patients With Late-Life Depression: Where Do We Go Next?
Taylor, W. D. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3458
Predicting Medication Response in Older Depressed Patients
Yager, J. (2013) · Journal watch · doi:10.1056/jp201304290000001
Lokko, H. N., Öngür, D., Gunderson, J. G., & Chen, J. A. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000107
“Strong reasons support the view that a consistent, supportive psychotherapeutic presence provides such help to patients with major depressive disorder to the extent that antidepressant medication might be considered adjunctive.(1) As will be discussed below, both group and family interventions would almost surely be a…”
BackgroundAntidepressant Therapy in Older Adults: A Meta-Analysis
Brett, A. S. (2013) · Journal watch · doi:10.1056/nejm-jw.na31392
Pharmacological Management of Anxiety and Depression in Older People
Wilkinson, P., & Behrman, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-29492-6_9
McCue, R. E., & Kelleher, M. (2017) · Wiley eBooks · doi:10.1002/9781119152606.ch12
Karim, H. T. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
More, S., Mishra, P., Tiwari, A., & Vyas, S. (2018) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20183478
“About 1-5% of elderly people suffer from depression.(7) People are most likely to suffer their first depressive episode between the ages of 30 and 40 years, and there is a second, smaller peak of incidence between ages 50 and 60 years.”
BackgroundSuicide in the Geriatric Population: Risk Factors, Identification, and Management
Shenava, M., Hitching, R., & Dunn, L. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-10401-6_8
Pharmacotherapy for late-life depression
Han, K. (2022) · Journal of Korean Medical Association · doi:10.5124/jkma.2022.65.3.176
“그간의 많은 연구들이 노인 인 구에서 위약 대비 항우울제의 유의한 치료 반응을 보고했음 에도 불구하고[7], 노인 인구에서 약물치료의 부작용에 대 한 높은 취약성 등으로 인해 최적의 용량에 비해 낮은 용량 (suboptimal dose) 또는 충분하지 못한 기간 동안 항우울제 치료가 이뤄지는 경우가 많다[2,3,8].”
Neuropsychiatric Symptoms (NPS) and Neurocognitive Disorders
Bhojani, Z., Ghodasara, S., Patience, J., Ross, E., Hitching, R., Fenn, H. H., & Burhan, A. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-53976-3_5
Mihalik-Wenger, A. C., Suryadevara, U., Wenger, J., Nuthi, M., Hitching, R., & Fenn, H. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-53976-3_11
Yang, X., Park, K., Kong, C. H., Cho, Y., Kim, D. Y., Kim, J. Y., Min, J. W., Jung, S. Y., & Ryu, J. H. (2024) · Natural Product Sciences · doi:10.20307/nps.2024.30.2.93
Balikci, B., & Dönmezdil, S. (2024) · doi:10.69860/nobel.9786053359456.10
Gelfand, L. A., Lorenzo‐Luaces, L., Dalvie, A., Mambula, L., & DeRubeis, R. J. (2025) · Behaviour Research and Therapy · doi:10.1016/j.brat.2025.104937
Reber, S. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-32176
Aydemir, Ö., Akdeniz, F., Özbaran, B., Özgündüz, C. M., Karaş, H., Özgüven, H. D., Yılancıoğlu, H. Y., Alkan, M., Uygur, Ö. F., Eker, Ö., et al. (2026) · Turkish Journal of Psychiatry · doi:10.5080/u27872
Vascular Depression and the Role of Neuroimaging and Biomarkers
Weisenbach, S. L., Gabel, N., & Briceño, E. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-16045-0_5
“A meta-analysis of patient-level variables demonstrated that duration of depressive symptoms and baseline depression severity signifi cantly predicts response to antidepressant treatment in LLD, with chronically depressed older patients with moderate-to-severe symptoms at baseline experiencing more improvement in symp…”
Method
Metadata
- Authors
- Nelson, J. C., Delucchi, K. L., & Schneider, L. S.
- Affiliations
- University of Southern California (US)
- Venue
- American Journal of Psychiatry
- Published
- 2013-06
- Volume
- 170
- Issue
- 6
- Pages
- 651-659
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2171199381
- Cited by
- 80
- References
- 72
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 9 · 2016: 11 · 2015: 9 · 2014: 9 · 2013: 4
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- geriatric depression, major depressive disorder, antidepressants, second-generation antidepressants, treatment moderators, disease duration, baseline depression severity, older adults, individual patient data, treatment response rate
- MeSH terms
- Age Factors, Aged, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Recurrence, Time Factors, Multivariate Analysis, Logistic Models, Treatment Outcome, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.